Gefitinib for advanced bronchioloalveolar carcinoma / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 340-343, 2004.
Artigo
em Chinês
| WPRIM
| ID: wpr-231932
ABSTRACT
We described 3 cases of advanced bronchioloalveolar carcinoma (BAC), in whom once-daily treatment with 250 mg Gefitinib (Iressa) demonstrated remarkable antitumor effects. Gefitinib may produce dramatic clinical responses when administered to patients with poor performance status who had received heavy platinum/docetaxel-based prior chemotherapy.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Quinazolinas
/
Adenocarcinoma Bronquioloalveolar
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Receptores ErbB
/
Neoplasias Pulmonares
/
Antineoplásicos
Limite:
Idoso
/
Feminino
/
Humanos
Idioma:
Chinês
Revista:
Acta Academiae Medicinae Sinicae
Ano de publicação:
2004
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS